Strides Pharma Inc.: Drug Recall

Recall #D-0180-2021 · 12/22/2020

Class III: Low Risk

Recall Details

Recall Number: D-0180-2021
Classification: Class III
Product Type: Drug
Recalling Firm: Strides Pharma Inc.
Status: Terminated
Date Initiated: 12/22/2020
Location: East Brunswick, NJ, United States
Voluntary/Mandated: Voluntary: Firm initiated
Product Quantity: 960 bottles

Reason for Recall

Failed Moisture Limits

Product Description

NDC 64380-721-06 TACROLIMUS CAPSULES, USP 1mg 100 Capsules Rx Only Manufactured by: Strides Pharma Science Ltd. Bengaluru - 562106, India Distributed by: Strides Pharma Inc. East Brunswick, NJ 08816

Distribution Pattern

Other Recalls by Strides Pharma Inc.

Class II: Risk 07/09/2025

Failed Dissolution Specifications.
Class II: Risk 03/05/2025

Presence of foreign substance: Presence of Benzene.
Class II: Risk 03/05/2025

Presence of foreign substance: Presence of Benzene.
Class II: Risk 12/29/2023

Failed Dissolution Specifications
Class II: Risk 06/26/2023

Presence of Foreign Substance: Presence of a small piece of blue plastic embedded in the tablet.

View all recalls by Strides Pharma Inc. →

Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.